UAB "Swixx Biopharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
5,166,407 |
127,786 |
301,363 |
264,118 |
6,533 |
84.06 |
5.11 |
602,793 |
580,246 |
96,663 |
1,035,103 |
2023 |
---|
5,786,464 |
138,797 |
381,645 |
302,989 |
7,268 |
84.57 |
5.24 |
905,783 |
769,783 |
109,242 |
1,466,233 |
2024 |
---|
5,753,408 |
130,908 |
325,690 |
273,862 |
6,231 |
83.68 |
4.76 |
1,179,645 |
786,347 |
82,301 |
1,811,460 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
5,753,408 €-1 % *
Sales per employee (€)
130,908 €-6 % *
Profit before tax (€)
325,690 €-15 % *
Net Profit (€)
273,862 €-10 % *
Profit per employee (€)
6,231 €-14 % *
Total profitability (%)
83.68 %-1.05 % *
Net profitability (%)
4.76 %-9.16 % *
Equity (€)
1,179,645 €30 % *
Amounts Payable And Liabilities (€)
786,347 €2 % *
Non-current Assets (€)
82,301 €-25 % *
CurrentAssets (€)
1,811,460 €24 % *